Anti-Müllerian hormone and pregnancy after autologous hematopoietic stem cell transplantation for multiple sclerosis

Autologous hematopoietic stem cell transplantation (AHSCT) has been approved for multiple sclerosis (MS) in many European countries. A large proportion of patients are women of child-bearing age. For them, AHSCT may have negative consequences for reproductive health, since the ovaries are particular...

Full description

Bibliographic Details

Published in:	PLoS ONE
Main Authors:	Lida Zafeiri, Torbjörn Åkerfeldt, Andreas Tolf, Kristina Carlson, Alkistis Skalkidou, Joachim Burman
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-01-01
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096464/?tool=EBI